GlassScriptPhysician profile
Chad Allen Squire
NPI 1063728905
$6,546.01
in general payments reported to CMS, 2019-2025
14 companies · $27.68 in 2025
The $27.68 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $18.33 · 2021: $12.08 · 2022: $5,375 · 2023: $98.17 · 2024: $497 · 2025: $27.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350 · Travel and Lodging: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.98 |
| Travel and Lodging | $273.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,571.16 | 2022 | |
| Impactortho, INC. | $1,135.72 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $352.04 | 2019 | |
| Goode Surgical INC | $139.36 | 2019 | |
| Stryker Corporation | $92.65 | 2023-2024 | T2 Alpha, Hydroset, Augment Injectable |
| Orthofix Medical, INC. | $91.80 | 2021-2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $35.92 | 2024-2025 | Nuzyra |
| Bioventus LLC | $25.52 | 2023 | Exogen Ultrasound Bone Healing System |
| Abbvie INC. | $19.99 | 2022 | |
| Nevro Corp. | $18.81 | 2024 | Senza |
| Krystal Biotech INC | $18.49 | 2024 | Vyjuvek |
| Kci USA, INC. | $18.33 | 2020 | |
| Organogenesis INC. | $14.92 | 2019 | |
| Merck Sharp & Dohme LLC | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Squire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.